Summa Biotech
Summa Biotech is a medical biotech company that is founded in 2022 and focuses on developing ground-breaking RNA-based medicines that reverse the damage of ischemic heart disease, which is a leading cause of death worldwide. We aim restore damaged heart tissue by eliciting the regeneration of healthy cells and tissues using RNA therapeutics. Summa Biotech’s strategy is to develop game-changing curative therapies for ischemic heart disease by leveraging academic expertise, cutting-edge disease models and fostering a culture of team excellence.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Summa Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- BV
Britt van de Water
Research Technician · Science
EmailPhone - GS
Giulia Spanò
Associate Researcher · Science
EmailPhone - RZ
Ralf Zaal
Founder at Summa Biotech Bv · Other
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Summa Biotech
3 distinct titles indexed · top 3 shown.
- 1associate researcher
- 1founder at summa biotech bv
- 1research technician
Sign up to unlock all 3 contacts at Summa Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Summa Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.